Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

DOSTARLIMAB vs DOXAZOSIN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

DOSTARLIMAB vs DOXAZOSIN: Safety Overview

Metric DOSTARLIMAB DOXAZOSIN
Total FAERS Reports 893 4,741
Deaths Reported 130 256
Death Rate 14.6% 5.4%
Hospitalizations 441 2,065
Average Patient Age 65.8 yrs 67.2 yrs
% Female Patients 91.6% 33.8%
FDA Approval Date N/A Apr 17, 2018
Manufacturer GlaxoSmithKline LLC A-S Medication Solutions
Route INTRAVENOUS ORAL
Marketing Status N/A Prescription